Delivery Order SPE2DB20D3101-SPE2DB23FRDY7
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $43,346.80 for the delivery of ELIQUIS 5 MG TABLET 60S. The contract is issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp., a subsidiary of Cencora, Inc., is a Delivery Order valued at $7,261.79 for the supply of ELIQUIS 5 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), which is a component of the Department of Defense (DoD) responsible for providing supplies and services to the U.S. military. The contract has an ultimate completion date of March 9, 2023 and is a Firm Fixed Price arrangement. There is no set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $22,047.40 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of October 25, 2023. Amerisourcebergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $13,336.46 for the supply of ELIQUIS 5 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $31,338.68 firm fixed-price delivery order is for the pharmaceutical product ELIQUIS 5 MG TABLET 60S, with a period of performance through May 4, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4563667106 ELIQUIS 5 MG TABLET 60S. The award, valued at $23,606.01, is a firm fixed-price delivery order contract with a completion date of February 15, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ELIQUIS 5 MG TABLET 60S. The contract, valued at $13,504.55, has a firm fixed price pricing type and an ultimate completion date of March 7, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. This contract award is not designated as a set-aside and represents an open competition for the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price of $3,802.33 for the supply of ELIQUIS 5 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an Ultimate Completion Date of May 16, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,248.58 firm fixed-price delivery order is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of May 1, 2025 and is not set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,204.11 for the supply of ELIQUIS 5 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating it was competed openly. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRDY7Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $12,547.61 for the pharmaceutical product ELIQUIS 5 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. military. The contract has a firm fixed price and an ultimate completion date of March 2, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical through December 2025. This IDC serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.5k | 3/1/23 |